FilingReader Intelligence
Zhaoke Ophthalmology revenue surges, losses narrow in 2024
March 27, 2025 at 05:33 PM UTC•By FilingReader AI
Zhaoke Ophthalmology announced its 2024 annual results, showcasing substantial revenue growth, climbing to RMB69.3 million from RMB18.8 million the previous year. The surge was fueled by a fivefold increase in ophthalmic drug sales, reaching RMB30.4 million, and RMB33.5 million in licensing income. The company's net loss decreased to RMB237.5 million, an improvement from RMB385.0 million in 2023.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:6622•Hong Kong Exchange
News Alerts
Get instant email alerts when Zhaoke Ophthalmology publishes news
Free account required • Unsubscribe anytime